Molecular and developmental mechanisms of phosducin-like protein 3 function in spermatogenesis
Active Grant Awarded
- Award ID
- R15HD122211
- Recipient
-
Loyola University Of Chicago UEI CVNBL4GDUKF3
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $545,625
Award facts
- Assistance listing
- 93.865 Child Health and Human Development Extramural Research
- Completion date 14% complete
- Place of performance
- Chicago, IL 60660, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services' National Institutes of Health, through the National Institute of Child Health and Human Development, awarded Loyola University of Chicago (doing business as Lake Shore Campus) a grant totaling $545,625 on June 19, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award funds research on the molecular and developmental mechanisms of phosducin-like protein 3 (PHLP3) in spermatogenesis. The investigators hypothesize that PHLP3 is necessary for the cytoskeletal changes that drive spermatid nuclear elongation and sperm individualization, and that PHLP3's conserved redox activity is essential to its biological function. The first stated aim identifies the key cysteine(s) involved in PHLP3's biochemical function. The full dollar amount is obligated, with a period of performance running from June 19, 2026 through the ultimate completion date of June 30, 2029. Work is performed in Chicago, Illinois, 60660. The assistance type is a grant.
Description
- Abstract
- Approximately 10-15% of couples in the united states experience infertility. In one-third of these cases, infertility is linked to male factors, primarily due to abnormal sperm production and function. Addressing this issue requires identifying and characterizing the genetic mechanisms that control sperm production. Recently, we identified the drosophila phosducin-like protein 3 (PHLP3) as essential for male fertility. PHLP3 mutant males are sterile and cannot produce mature sperm. Spermatid nuclei fail to cluster, complete nuclear elongation, and individualize, resulting in seminal vesicles without sperm and sterility. To understand how PHLP3 functions in vivo, IT's important to consider its molecular role. PHLP3 belongs to a family of small thioredoxin- domain-containing proteins that are highly conserved among all eukaryotes. Members of the PHLP3 family exhibit cysteine-dependent redox activity, and their functions are linked to the regulation of microtubules and actin filaments. Recent studies have shown conservation of this redox activity across species, from the protozoan parasite plasmodium berghei to humans and drosophila, although the cysteine dependence of drosophila PHLP3'S redox activity has not yet been confirmed. Given the proposed role for PHLP3 as a regulator of cytoskeletal proteins and the critical importance of cytoskeletal remodeling during spermatid maturation, we hypothesize that PHLP3 is necessary for the cytoskeletal changes that promote nuclear elongation and sperm individualization. We also hypothesize that the conserved redox activity of PHLP3 is essential for its biological function. This project aims to elucidate the molecular and developmental mechanisms of PHLP3 function during spermatogenesis through a multi-faceted approach: (1) understanding the biochemical function of PHLP3 by identifying the key cysteine(S) involved in redox activity and its in vivo binding partners, and (2) characterizing the tissue and subcellular localization of PHLP3 and examining how PHLP3 mutations affect critical stages of late spermatogenesis. These studies will shed light on the biochemical and genetic mechanisms by which PHLP3 regulates spermatogenesis. Considering the high level of sequence conservation across species, we propose that PHLP3 performs similar functions related to spermatogenesis across different organisms.
Quick answers
Who received award R15HD122211?
R15HD122211 was awarded to Loyola University Of Chicago by National Institute of Child Health and Human Development (National Institutes of Health) on June 19, 2026.
How much is award R15HD122211 worth?
$545,625 has been obligated on R15HD122211.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award